|
- Cardiovascular medical devices: Stent manufacturer | Medinol
The Medinol Group designs and manufactures high-quality stents using innovative techniques and materials to improve patient outcomes Our expert team provides customized solutions that meet customer needs
- Medinol | LinkedIn
Medinol is dedicated to the science of cardiovascular intervention For over 25 years, we have delivered over two million coronary stents to patients worldwide
- Israeli Heart Sensor Implanted in First U. S. Patients
Israeli company Medinol, through its subsidiary Microtech, has announced the first implantations in the U S of its innovative heart-pressure sensor designed to monitor atrial pressure in patients with heart failure
- Medinol’s EluNir-Perl Coronary DES Approved by FDA
October 24, 2023—Medinol announced United States FDA approval for the EluNir-Perl drug-eluting stent (DES) for the treatment of coronary artery
- Medinol has first human implant of drug-eluting peripheral stent
Medinol today announced the successful first-in-human implantation of its ChampioNIR drug-eluting peripheral stent Dr Gerard S Goh and Dr Thodur Vasudevan of the Alfred Hospital in Melbourne, Australia, completed the stent implant
- Medinol Receives FDA Approval for Next Generation EluNIR-PERL™ Drug . . .
About Medinol At Medinol, we are aggressively changing paradigms in how disease states are diagnosed and treated
- About Medinol Group, Pioneers In Cardiovascular Medical Devices
Medinol’s products constantly stretch the limits of innovation; the scientific spirit that led the company to pioneer the revolutionary NIR stent in 1996 still drives its multidisciplinary team today
- Medinol Archives - Cardiac Vascular News
Medinol, a global Interventional Cardiology device company, announced that it obtained CE-mark for EluNIR™, its novel Drug Eluting Stent featuring a unique stent design with low metal footprint and a proprietary elastomeric coating, both designed to optimize clinical outcomes
|
|
|